Myeloproliferative neoplasms are associated with an increased risk for arterial and venous thrombosis, according to a population-based study of Swedish registries.

News

Myeloproliferative neoplasms are associated with an increased risk for arterial and venous thrombosis, according to a population-based study of Swedish registries.
The relationship between transfusion dependency and health-related quality of life in patients with myelodysplastic syndromes may differ based on disease risk at diagnosis.
The hypomethylating agents decitabine and azacitidine administered at a low dose is safe and effective for patients with lower-risk myelodysplastic syndrome and myeloproliferative neoplasms.

Quiz

Updated NCCN guidelines for myeloproliferative neoplasms offer which of the following options for the management of myelofibrosis-associated anemia?

Resources

The National Comprehensive Cancer Network has released updates to their guidelines for myeloproliferative neoplasms, including management suggestions for related disorders and testing options.
Subscribe to Myeloproliferative Neoplasms